# Generic Animal Drug Advancement Act

This bill makes it easier for companies to create and sell generic versions of animal medications. Right now, when a pharmaceutical company wants to bring a generic animal drug to market, they have to prove it works the same way as the original drug across every single species that the original drug is approved for. This bill changes that requirement so companies only need to prove their generic version works in at least one major species where the original drug is approved, or in one species if the original drug isn't approved for any major species.

Think of it like this: if a medication is approved for use in cattle, horses, and chickens, a generic manufacturer currently has to test and prove their version works identically in all three animals. Under this new bill, they'd only need to prove it works in one of them—likely the most common or economically important one. This should speed up the approval process and reduce the cost of developing generic animal drugs, which could eventually make these medications cheaper for farmers and pet owners.

The bill also clarifies some technical language in the existing drug approval law to make the process clearer and more straightforward. These changes are aimed at encouraging more generic animal drug manufacturers to enter the market, which typically leads to lower prices through competition. The practical effect for everyday people would mainly be lower costs for veterinary medications and animal treatments, though the changes primarily benefit the agricultural and veterinary pharmaceutical industries by reducing their regulatory burden.

Generic Animal Drug Advancement Act

Mace, Nancy

Generic Animal Drug Advancement Act This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)